Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of PEG Chain Length on the Water Solubility of Monodisperse PEG-Appended Molecules.

The journal of physical chemistry. B·2026
Same author

intDesc-AbMut: A Tool for Describing and Understanding How Antibody Mutations Impact Their Environmental Interactions.

Computational and structural biotechnology journal·2026
Same author

Data-Driven Design of PROTAC Linkers to Improve PROTAC Cell Membrane Permeability.

JACS Au·2026
Same author

Quantitative Structure-Activity Relationships for Human Galectin-3 Inhibitors: Insights from Quantum Chemical Interaction Energy Terms.

Journal of chemical information and modeling·2025
Same author

Molecular Dynamics Unveils Multiple-Site Binding of Inhibitors with Reduced Activity on the Surface of Dihydrofolate Reductase.

Journal of the American Chemical Society·2024
Same author

Statistical-Mechanics Analyses on Thermodynamics of Protein Folding Constructed by Privalov and Co-Workers.

The journal of physical chemistry. B·2024
Same journal

Repurposing bleomycin against Acinetobacter baumannii HisG: computational, biophysical, and antibacterial evidence.

Journal of computer-aided molecular design·2026
Same journal

Topological data analysis for antibody-drug conjugate payload discovery: a computational framework for mechanistic classification and target validation.

Journal of computer-aided molecular design·2026
Same journal

Commentary on the fundamentals and development of artificial intelligence models in the life sciences and best research practices.

Journal of computer-aided molecular design·2026
Same journal

RANQSAR: a standalone open-source application for reproducible machine learning-based QSAR analysis.

Journal of computer-aided molecular design·2026
Same journal

Integrating evolutionary and compositional features with ML and DL for robust and interpretable druggable protein prediction.

Journal of computer-aided molecular design·2026
Same journal

QUAD: a composite risk framework integrating uncertainty, applicability domain, and model disagreement for reliable QSAR predictions.

Journal of computer-aided molecular design·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.7K

In silico-driven protocol for hit-to-lead optimization: a case study on PDE9A inhibitors.

Hiroyuki Ogawa1,2, Masateru Ohta3, Mitsunori Ikeguchi4,5

  • 1Graduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Journal of Computer-Aided Molecular Design
|December 18, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces an in silico hit-to-lead (H2L) optimization protocol. It uses molecular generation, non-equilibrium switching (NES) for binding affinity, and machine learning (ML) for ADME properties to explore chemical space efficiently.

Keywords:
Drug discoveryHit-to-leadNon-equilibrium switchingPDE9A

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.4K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.4K

Related Experiment Videos

Last Updated: Jan 7, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.7K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.4K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.4K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Medicinal chemistry

Background:

  • Hit-to-lead (H2L) optimization is crucial for small-molecule drug discovery.
  • Traditional H2L methods limit chemical space exploration due to iterative synthesis and evaluation.
  • In silico approaches offer efficient exploration of vast chemical spaces via virtual compound generation and computational evaluation.

Purpose of the Study:

  • To develop and validate an in silico-driven H2L protocol for efficient chemical space exploration.
  • To assess the accuracy and utility of the non-equilibrium switching (NES) method for binding free energy calculations in H2L.
  • To integrate molecular generation, NES-based affinity prediction, and machine learning (ML) for ADME property evaluation.

Main Methods:

  • Developed an integrated in silico H2L protocol combining molecular generation, NES for relative binding free energy calculations, and ML for ADME property prediction (solubility, metabolic stability, permeability).
  • Applied the protocol to a phosphodiesterase 9A inhibitor model system, starting from a high-throughput screening hit.
  • Conducted large-scale exploration of substituent space at two key positions.

Main Results:

  • The in silico protocol successfully identified compounds with high predicted binding affinity and favorable ADME properties.
  • The lead compound previously reported in the literature was identified among the top-ranked candidates.
  • NES method demonstrated effectiveness in large-scale substituent space exploration for H2L optimization.

Conclusions:

  • An in silico H2L protocol integrating large-scale molecular generation, high-accuracy NES affinity prediction, and ML-based ADME prediction enables broader exploration of substituent space.
  • This approach accelerates the identification of promising drug candidates with desirable properties.
  • The study validates the utility of NES for precise binding free energy calculations in drug discovery workflows.